Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 ...
Top-line results from SUMMIT trial in NonAdvSM patients expected July 2025• APEX trial enrollment in AdvSM patients complete; top-line results ...
Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th ...
TERN-701 CARDINAL study progressing well; dose expansion expected to initiate in 2Q25 with additional safety and efficacy data in 4Q25New ...
manilatimes33 分钟
Kangpu Biopharmaceuticals Received IND Approval from NMPA for KPG-818 to Treat Relapsed ...
Kangpu Biopharmaceuticals, Ltd. ('Kangpu') today announced that the Company has received IND approval from the CDE (Center ...
manilatimes10 分钟
Alkeus Pharmaceuticals Announces Establishment of Scientific Advisory Board
Director of Artificial Intelligence & Imaging Research at the Doheny Eye Institute, and Professor of Ophthalmology at the ...
Tiziana Life Sciences Ltd.: Tiziana Life Sciences Announces Long Covid Study to Complete in ...
NEW YORK, Feb. 25, 2025) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully hum ...